Duoning

Duoning is a bioprocess company based in China, providing innovative solutions to the life science industry. Since its establishment in 2005, it has established itself as a leader in the biotechnology and health care sectors. The company offers a comprehensive range of products and services, including upstream technologies such as cell culture media and bioreactors, as well as downstream solutions like chromatography resin and filters. Notably, Duoning also provides a complete single-use solution for fluid management, high-pressure homogenizers, and pure water systems for laboratory and industrial use.

The company recently secured a significant Series C investment on 24 November 2021 from a group of prominent investors, including GL Capital, Sequoia China, Lake Bleu Capital (Hong Kong) Limited, and 99Fund. This funding will further bolster Duoning's multi-site manufacturing net, ensuring a resilient supply chain and continuity for its customers' business operations.